Scutellarin suppresses neuroinflammation via the inhibition of the AKT/NF-κB and p38/JNK pathway in LPS-induced BV-2 microglial cells
Affiliations
- 1 Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine, 1 HuangJia Hu Road West, Hongshan District, Wuhan, Hubei, 430065, People’s Republic of China. tptyou@hbtcm.edu.cn.
- 2 Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine, 1 HuangJia Hu Road West, Hongshan District, Wuhan, Hubei, 430065, People’s Republic of China.
- 3 School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, 430065, People’s Republic of China.
- PMID: 29680917
- DOI: 10.1007/s00210-018-1503-7
Abstract
In vitro and in vivo studies indicate that scutellarin (SCU) exerts anti-inflammatory effects in the central nervous system (CNS) and inhibits microglia activation. This study investigated the anti-neuroinflammation molecular mechanisms exerted by scutellarin in LPS-induced BV-2 cells. The results showed that production of TNF-α, IL-1β, IL-6, and NO and TNF-α, IL-1β, IL-6, and iNOS mRNA were inhibited by scutellarin, which was independent of cytotoxicity as assessed by a CCK8 assay. Western blot analysis indicated that NF-κB-p65 phosphorylation was suppressed by scutellarin via inhibition of IκB degradation and IKKβ activation, which coincided with blockage of nuclear translocation of NF-κB as shown by immunofluorescent staining. Consistent with the inhibition of NF-κB, scutellarin inhibited the phosphorylation of p38, JNK, and AKT without affecting phosphorylation of ERK1/2 or PI3K in LPS-induced BV-2 cells. Overall, the present study suggests that scutellarin inhibits the production of pro-inflammatory mediators via inhibition of the IKK-dependent NF-κB and p38/JNK signaling pathway, which inhibits microglia activation and exerts anti-inflammation, indicating its potential therapeutic effect for neurodegenerative and cerebrovascular diseases.
Keywords: Activation; Microglia; Pro-inflammatory mediators; Scutellarin; Signaling.
https://doi.org/10.1007/s00210-018-1503-7
Cell Counting Kit-8 (CCK-8) 已有 26 篇已发表文献
同类研究
- Drug Deliv Transl Res. 2025 Oct;15(10):3695-3715.doi: 10.1007/s13346-025-01828-6. Epub 2025 Mar 6. Two-step ultrasonic c…
- Cell. 2025 Feb 20;188(4):1119-1136.e23.doi: 10.1016/j.cell.2024.12.010. Epub 2025 Jan 17. Hyperacute rejection-engineere…
- Am J Transl Res. 2025 Feb 15;17(2):888-896.doi: 10.62347/NPLT8946. eCollection 2025. MiR-145-5p inhibits proliferation o…
- Biomed Pharmacother. 2022 Oct;154:113529.doi: 10.1016/j.biopha.2022.113529. Epub 2022 Aug 26. (IF7.419) Praeruptorin B i…
- Front Oncol. 2022 Jul 14;12:882202.doi: 10.3389/fonc.2022.882202. eCollection 2022. (IF5.738) SETD3 Methyltransferase Re…
